Clinical Trials in Tōon, Japan
Locations / Tōon, Japan
Delta Trials hosts 135 clinical trials conducted in Tōon, Japan, making it a notable site of clinical research activity. These trials covering 157 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 6 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Tōon.
135
Total Trials
157
Conditions
6
Terminated since 2020
Browse by condition (157 total)
- Ovarian cancer 8 trialsAll Ovarian cancer trials
- Non-small cell lung cancer 7 trialsAll Non-small cell lung cancer trials
- Parkinson's disease 5 trialsAll Parkinson's disease trials
- Alzheimer's disease 4 trialsAll Alzheimer's disease trials
- Fallopian tube cancer 4 trialsAll Fallopian tube cancer trials
- Endometrial neoplasms 4 trialsAll Endometrial neoplasms trials
- Crohn's disease 3 trialsAll Crohn's disease trials
- Primary peritoneal cancer 3 trialsAll Primary peritoneal cancer trials
- Cervical cancer 3 trialsAll Cervical cancer trials
- Urothelial carcinoma 3 trialsAll Urothelial carcinoma trials
- Essential thrombocythemia 3 trialsAll Essential thrombocythemia trials
- Carcinoma, renal cell 3 trialsAll Carcinoma, renal cell trials
- Palmoplantar pustulosis 2 trialsAll Palmoplantar pustulosis trials
- Stereotypical prolonged seizures 2 trialsAll Stereotypical prolonged seizures trials
- Relapsing multiple sclerosis 2 trialsAll Relapsing multiple sclerosis trials
- Nonalcoholic fatty liver disease 2 trialsAll Nonalcoholic fatty liver disease trials
- Nonalcoholic steatohepatitis 2 trialsAll Nonalcoholic steatohepatitis trials
- Chronic hepatitis c virus 2 trialsAll Chronic hepatitis c virus trials
- Non-small cell lung cancer (nsclc) 2 trialsAll Non-small cell lung cancer (nsclc) trials
- Adult t-cell leukemia/lymphoma 2 trialsAll Adult t-cell leukemia/lymphoma trials